Thomas F. Frist III - 04 Nov 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Nov 2026, 18:04:41 UTC
Prior SEC filing
30 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ J. William B. Morrow, Attorney-in-Fact
Filing notes and source

Key filing fact

Thomas F. Frist III filed Form 4 for HCA Healthcare, Inc. (HCA) on 06 Nov 2026.

Key facts

  • This page summarizes Thomas F. Frist III's Form 4 filing for HCA Healthcare, Inc. (HCA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Nov 2026, 18:04.

Change

  • Previous filing in this sequence was filed on 30 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001223892 Primary reporting owner

FRIST THOMAS F III

Relationship
Director, 10%+ Owner
Address
3100 WEST END AVENUE, NASHVILLE
Signature
/s/ J. William B. Morrow, Attorney-in-Fact
Signature date
06 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock, par value $0.01 per share

Other

Transaction value
Shares
-555,500
Change %
-1.7%
Price
$503.52*
Shares after
32,282,889
Date
04 Nov 2026
Ownership
By Hercules Holding II
Footnotes
F1, F4
HCA transaction

Common Stock, par value $0.01 per share

Other

Transaction value
Shares
+555,500
Change %
+1.8%
Price
$503.52*
Shares after
32,282,889
Date
04 Nov 2026
Ownership
By Hercules Holding II
Footnotes
F1, F4
HCA holding

Common Stock, par value $0.01 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,858
Date
04 Nov 2026
Ownership
Direct
Footnotes
F2
HCA holding

Common Stock, par value $0.01 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
36,557,141
Date
04 Nov 2026
Ownership
By Frisco Holding II
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Hercules Holding II ("Hercules") holds 32,282,889 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"). Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 3,034,522 Shares by the Reporting Person; 9,497 Shares by the Reporting Person's spouse; and 3,965,851 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee.

Footnote F2

This number represents restricted share units payable in Shares, which will be delivered to the Reporting Person on the date he ceases to be a director of the Issuer.

Footnote F3

Frisco Holding II ("Frisco") holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 1,172 Shares by the Reporting Person; and 11,868,140 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee.

Footnote F4

On November 4, 2026, the Reporting Person transferred a total 555,500 units of Hercules to trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee in satisfaction of obligations. Each of these transfers was made at a price per unit of Hercules equal to $503.525 (the average of the high and low prices of the Shares on November 4, 2026). In each case, these transfers did not change the total number of Shares of which the Reporting Person may be deemed to have beneficial ownership.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .